A hemispheric asymmetry is known for the processing of global vs. local visual information. In this study, we investigated the existence of a hemispheric asymmetry for visual processing of low vs. high spatial frequency gratings. Event-related potentials were recorded in a group of healthy right-handed volunteers from 30 scalp sites. Six types of stimuli (1.5, 3 and 6 c/deg gratings) were randomly flashed 180 times in the left and right upper hemi-fields. Stimulus duration was 80 ms and ISI ranged between 850-1000 ms. Participants had to pay attention and respond to targets based on their spatial frequency and location, or to passively look at the stimuli. C1 and P1 visual responses, as well as a later Selection negativity and a P300 components of ERPs were quantified and subjected to repeated-measure ANOVAs. Overall, performance was faster for the RVF, thus suggesting a left hemispheric advantage for attentional selection of local elements. Similarly, the analysis of mean area amplitude of C1 (60-110 ms) sensory response showed a stronger attentional effect (F+L+ vs. F-L+) at left occipital areas, thus suggesting the sensory nature of this hemispheric asymmetry.

During COVID-19 pandemic, drug repurposing represented an effective strategy to obtain quick answers to medical emergencies. Basing on previous data on Methotrexate (MTX), we evaluated the anti-viral activity of several DHFR inhibitors in two cell lines. We observed that this class of compounds showed a significant influence on the virus-induced cytopathic effect (CPE) partly associated to the intrinsic antimetabolic activity of these drugs, but also to a specific antiviral function. To elucidate the molecular mechanisms, we took advantage of our EXSCALATE platform for in-silico molecular modelling and further validated the influence of these inhibitors on nsp13 and viral entry. Interestingly, Pralatrexate and Trimetrexate showed superior effects in counteracting the viral infection compared to other DHFR inhibitors. Our results indicate that their higher activity is due to their polypharmacological and pleiotropic profile. These compounds can thus potentially give a clinical advantage in the management of SARS-CoV-2 infection in patients already treated with this class of drugs.